RenalGuard system in high-risk patients for contrast-induced acute kidney injury

American Heart Journal

Volumn 173, Issue , 2016, Pages 67-76

  Briguori, Carlo ^a   Visconti, Gabriella ^a   Donahue, Michael ^a   De Micco, Francesca ^a   Focaccio, Amelia ^a   Golia, Bruno ^a   Signoriello, Giuseppe ^b   Ciardiello, Carmine ^c   Donnarumma, Elvira ^d   Condorelli, Gerolama ^e  

^a Department of Cardiology   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Med Onc Pozzuoli   (Italy)

^d IRCCS SDN   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; POTASSIUM; CONTRAST MEDIUM; CREATININE; DIURETIC AGENT; DRUG COMBINATION; ISOTONIC SOLUTION; SODIUM CHLORIDE;

AGED; ARTICLE; CONTRAST INDUCED NEPHROPATHY; ELECTROLYTE DISTURBANCE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERNATREMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; INFUSION PUMP; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; URINE FLOW RATE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANGIOGRAPHY; BLOOD; CHEMICALLY INDUCED; CORONARY ARTERY DISEASE; DEVICES; DRUG COMBINATION; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; FOLLOW UP; PHYSIOLOGY; RADIOGRAPHY; URODYNAMICS;

ACUTE KIDNEY INJURY; AGED; ANGIOGRAPHY; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CREATININE; DIURETICS; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HUMANS; ISOTONIC SOLUTIONS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHLORIDE; URODYNAMICS;

EID: 84960343994     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.12.005     Document Type: Article

References (27)

1. P.A. McCullough Contrast-induced acute kidney injury J Am Coll Cardiol 51 15 2008 1419 1428
2. R.J. Solomon, R. Mehran, M.K. Natarajan, and et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 4 7 2009 1162 1169
3. Briguori C, Visconti G, Rivera NV, et al. Cystatin C and contrast-induced acute kidney injury. Circulation;121(19):2117-2122.
4. C. Briguori, G. Visconti, A. Focaccio, and et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury Circulation 124 11 2011 1260 1269
5. G. Marenzi, C. Ferrari, I. Marana, and et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial JACC Cardiovasc Interv 5 1 2012 90 97
6. J.F. Dorval, S.R. Dixon, R.B. Zelman, and et al. Feasibility study of the RenalGuard balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients Int J Cardiol 166 2 2013 482 486
7. R. Mehran, E.D. Aymong, E. Nikolsky, and et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 7 2004 1393 1399
8. H.S. Gurm, M. Seth, J. Kooiman, and et al. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention J Am Coll Cardiol 61 22 2013 2242 2248
9. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl. 1 2002 S1 S266
10. R.G. Cigarroa, R.A. Lange, R.H. Williams, and et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease Am J Med 86 6 Pt 1 1989 649 652
11. R.L. Mehta, J.A. Kellum, S.V. Shah, and et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2 2007 R31
12. M.A. Stevens, P.A. McCullough, K.J. Tobin, and et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation J Am Coll Cardiol 33 2 1999 403 411
13. G. Romano, C. Briguori, C. Quintavalle, and et al. Contrast agents and renal cell apoptosis Eur Heart J 29 20 2008 2569 2576
14. P.B. Persson, P. Hansell, and P. Liss Pathophysiology of contrast medium-induced nephropathy Kidney Int 68 1 2005 14 22
15. J. Tumlin, F. Stacul, A. Adam, and et al. Pathophysiology of contrast-induced nephropathy Am J Cardiol 98 6A 2006 14K 20K
16. J.H. Wang, W.C. Lin, C.J. Wei, and et al. Diagnostic value of unenhanced computerized tomography urography in the evaluation of acute renal colic Kaohsiung J Med Sci 19 10 2003 503 509
17. D.C. Brater, S.A. Anderson, and D. Brown-Cartwright Response to furosemide in chronic renal insufficiency: rationale for limited doses Clin Pharmacol Ther 40 2 1986 134 139
18. D.A. Sica Diuretic use in renal disease Nat Rev Nephrol 8 2 2012 100 109
19. L. Dobrowolski, B. B dzyńska, and J. Sadowski Differential effect of frusemide on renal medullary and cortical blood flow in the anaesthetised rat Exp Physiol 85 6 2000 783 789
20. T.M. Kennedy-Lydon, C. Crawford, S.S. Wildman, and et al. Renal pericytes: regulators of medullary blood flow Acta Physiol (Oxf) 207 2 2013 212 225
21. R. Solomon, C. Werner, D. Mann, and et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 21 1994 1416 1420
22. J.M. Weinstein, S. Heyman, and M. Brezis Potential deleterious effect of furosemide in radiocontrast nephropathy Nephron 62 4 1992 413 415
23. M. Oppermann, P.B. Hansen, H. Castrop, and et al. Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice Am J Physiol Renal Physiol 293 1 2007 F279 F287
24. P. Liss, A. Nygren, H.R. Ulfendahl, and et al. Effect of furosemide or mannitol before injection of a non-ionic contrast medium on intrarenal oxygen tension Adv Exp Med Biol 471 1999 353 359
25. G. Marenzi, I. Marana, G. Lauri, and et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration N Engl J Med 349 14 2003 1333 1340
26. S.S. Brar, V. Aharonian, P. Mansukhani, and et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial Lancet 383 9931 2014 1814 1823
27. S.W. Klarenbach, N. Pannu, M.A. Tonelli, and et al. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease Crit Care Med 34 4 2006 1044 1051